Nasal Congestion Relief Drop in pharma franchise in Tamil Nadu

Nasal Congestion Relief Drop in PCD pharma franchise in Gangtok

Nasal Congestion Relief Drop in top pharma company in Durg

Nasal Congestion Relief Drop in pcd pharma supplier in Shimla

Nasal Congestion Relief Drop in phama franchise company in India
Nasal Congestion Relief Drop in phama distributor in Vellore

Home/Products /oxymetazoline-hcl-i-point-p-0-point-025-w-v-benzalkonium-chloride-nasal-drop-nasal-drop

About the Product

Description


Oxyniff P Drop containing Oxymetazoline (0.025% w/v) is a topical nasal decongestant designed to relieve nasal congestion caused by colds, allergies, or sinusitis. Oxymetazoline works by constricting blood vessels in the nasal passages, thereby reducing swelling and allowing for easier airflow. This product provides fast and effective relief from nasal stuffiness, helping to clear blocked nasal passages and making breathing easier.

The effects of Oxyniff P Drop are typically felt within minutes, offering relief that lasts for several hours. This makes it especially useful for individuals experiencing short-term nasal congestion due to a cold or seasonal allergic rhinitis. The spray formulation ensures direct application to the nasal passages for fast relief.

Possible side effects include fatigue, dizziness, somnolence, irritability, and headache. Rarely, mood changes or allergic reactions may occur.

Lapcetam Solution Syrup is indicated for managing partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures in epilepsy patients.

This medication should be taken strictly under medical supervision. Avoid abrupt discontinuation, as it may lead to withdrawal seizures. Report any side effects or unusual symptoms to your doctor immediately.

Store at a temperature below 25°C in a dry, cool place. Protect from direct sunlight and keep out of reach of children. Once opened, use within the time specified by the manufacturer.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Oxymetazoline HCl IP 0.025% w/v + Benzalkonium Chloride Nasal Drops in the PCD pharma franchise market?

Oxymetazoline HCl IP 0.025% w/v + Benzalkonium Chloride Nasal Drops has strong demand in the ENT, pediatric care, respiratory care, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ENT and respiratory care portfolios.

Why should medical distributors include Oxymetazoline HCl IP 0.025% w/v + Benzalkonium Chloride Nasal Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for nasal congestion relief and upper respiratory care products. Oxymetazoline HCl 0.025% w/v is a nasal decongestant that helps reduce swelling of the nasal passages and improves airflow Benzalkonium Chloride acts as a preservative to maintain product stability and quality Commonly used for the temporary relief of nasal congestion associated with common cold, allergic rhinitis, sinusitis, and other upper respiratory conditions as advised by healthcare professionals Helps improve breathing comfort by reducing nasal blockage and congestion Nasal drop formulation allows easy administration, particularly in pediatric and ENT care settings Frequently utilized in ENT clinics, pediatric practices, hospitals, and general healthcare settings Widely recommended by ENT specialists, pediatricians, and general physicians This strengthens a comprehensive ENT and respiratory care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxymetazoline HCl IP 0.025% w/v + Benzalkonium Chloride Nasal Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong seasonal and year-round demand, repeat purchases, broad market acceptance, reliable supply chain support, and attractive margins in the ENT and respiratory care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.